Editorial: Novel Strategies for Anti-Tumor Vaccines

被引：7
|
作者：
Accolla, Roberto S. [1 ]
Buonaguro, Luigi [2 ]
Melief, Cornelis [3 ,4 ]
Rammensee, Hans-George [5 ]
Bassani-Sternberg, Michal [6 ]
机构：
[1] Univ Insubria, Sch Med, Dept Med & Surg, Varese, Italy
[2] Ist Nazl Tumori, Canc Immunoregulat Unit, IRCCS, Fond G Pascale, Naples, Italy
[3] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands
[4] ISA Pharmaceut, Leiden, Netherlands
[5] Univ Tubingen, Dept Immunol, Inst Cell Biol, Tubingen, Germany
[6] Univ Lausanne, Dept Oncol, Ludwig Inst Canc Res, Lausanne, Switzerland
来源：
FRONTIERS IN IMMUNOLOGY | 2020年 / 10卷
关键词：
tumor vaccine; HLA peptidome; tumor antigens; neoantigens; APC; T helper cells (Th);
D O I：
10.3389/fimmu.2019.03117
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Tumor vaccines: Toward multidimensional anti-tumor therapies
    Tan, Yuanfang
    Chen, Huiyuan
    Gou, Xi
    Fan, Qiuying
    Chen, Juanjuan
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [2] Induction of anti-tumor immunity by neoantigen vaccines
    Nagaoka, Koji
    Sato, Yasuyoshi
    Hosoi, Akihiro
    Matsushita, Hirokazu
    Kakimi, Kazuhiro
    [J]. CANCER SCIENCE, 2018, 109 : 275 - 275
  • [3] Therapeutic Anti-Tumor Vaccines: From Tumor Inhibition to Enhancement
    Chiarella, Paula
    Reffo, Veronica
    Bruzzo, Juan
    Bustuoabad, Oscar D.
    Ruggiero, Raul A.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 237 - 245
  • [4] From glycals to evaluatable anti-tumor vaccines.
    Ragupathi, G
    Livingston, PO
    Danishefsky, SJ
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U224 - U224
  • [5] Cancer vaccines: Harnessing the potential of anti-tumor immunity
    Suckow, Mark A.
    [J]. VETERINARY JOURNAL, 2013, 198 (01): : 28 - 33
  • [6] Anti-tumor vaccines based on stabilized mRNA (RNActive™)
    Probst, J.
    Scheel, B.
    Teufel, R.
    Hoerr, I.
    Rammensee, H. -G.
    Pascolo, S.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (03) : 420 - 420
  • [7] Selected anti-tumor vaccines merit a place in multimodal tumor therapies
    Weiss, Eva-Maria
    Wunderlich, Roland
    Ebel, Nina
    Hubner, Yvonne
    Schluecker, Eberhard
    Meyer-Pittroff, Roland
    Ott, Oliver J.
    Fietkau, Rainer
    Gaipl, Udo S.
    Frey, Benjamin
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [8] Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages
    Li, Si-Yuan
    Guo, Yong-Lin
    Tian, Jia-Wen
    Zhang, He-Jing
    Li, Rui-Fang
    Gong, Ping
    Yu, Zi-Li
    [J]. CANCERS, 2023, 15 (10)
  • [9] NOVEL ANTI-TUMOR ANTIBIOTICS, TETROCARCINS
    TOMITA, F
    TAMAOKI, T
    SHIRAHATA, K
    KASAI, M
    MORIMOTO, M
    OHKUBO, S
    MINEURA, K
    ISHII, S
    [J]. JOURNAL OF ANTIBIOTICS, 1980, 33 (06): : 668 - 670
  • [10] PROTHRACARCIN, A NOVEL ANTI-TUMOR ANTIBIOTIC
    SHIMIZU, K
    KAWAMOTO, I
    TOMITA, F
    MORIMOTO, M
    FUJIMOTO, K
    [J]. JOURNAL OF ANTIBIOTICS, 1982, 35 (08): : 972 - 978
12345